Virax Biolabs Group Limited Ordinary Shares (VRAX)

Price$0.21

Value ScoreD

Growth ScoreF

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-55.14%

Price vs S&P 500 (4W)24.28%

VGM Score26.63

Market Capitalization$4.78M

All Metrics

Book Value / Share (Quarterly)$0.81

P/TBV (Annual)0.32x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.90

Price vs S&P 500 (YTD)-46.71%

Gross Margin (TTM)-1515.05%

Net Profit Margin (TTM)-188748.83%

EPS (TTM)$-1.25

10-Day Avg Trading Volume7.69M

EPS Excl Extra (TTM)$-1.25

Revenue Growth (5Y)-42.42%

EPS (Annual)$-1.62

ROI (Annual)-99.80%

Gross Margin (Annual)-838.39%

Net Profit Margin (5Y Avg)-33013.30%

Cash / Share (Quarterly)$0.51

Revenue Growth QoQ (YoY)-67.47%

ROA (Last FY)-94.31%

Revenue Growth TTM (YoY)-96.48%

EBITD / Share (TTM)$-1.20

Operating Margin (TTM)-196303.34%

Cash Flow / Share (Annual)$-1.19

P/B Ratio0.90x

P/B Ratio (Quarterly)0.75x

Net Income / Employee (Annual)$-319,000

EV / Revenue (TTM)660.90x

Net Interest Coverage (TTM)-105.63x

ROA (TTM)-92.96%

EPS Incl Extra (Annual)$-1.62

Current Ratio (Annual)7.27x

Quick Ratio (Quarterly)9.63x

3-Month Avg Trading Volume21.37M

52-Week Price Return-78.12%

Revenue / Employee (TTM)$200

Tangible BV / Share (Quarterly)$2.09

P/S Ratio (Annual)755.70x

Asset Turnover (Annual)0.00x

52-Week High$1.14

Operating Margin (5Y Avg)-33933.65%

EPS Excl Extra (Annual)$-1.62

26-Week Price Return-47.22%

Quick Ratio (Annual)6.33x

13-Week Price Return2.66%

Total Debt / Equity (Annual)0.07x

Current Ratio (Quarterly)11.35x

Enterprise Value$1.98M

Revenue / Share Growth (5Y)-28.02%

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$300

Inventory Turnover (Annual)0.77x

Pretax Margin (Annual)-98007.74%

Cash / Share (Annual)$0.97

3-Month Return Std Dev230.36%

Gross Margin (5Y Avg)-156.08%

Net Income / Employee (TTM)$-297,000

ROE (Last FY)-106.41%

Net Interest Coverage (Annual)-92.23x

EPS Basic Excl Extra (Annual)$-1.62

Receivables Turnover (TTM)1.94x

Total Debt / Equity (Quarterly)0.10x

EPS Incl Extra (TTM)$-1.25

ROI (TTM)-94.67%

P/S Ratio (TTM)1599.87x

Pretax Margin (5Y Avg)-33474.66%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$2.09

Price vs S&P 500 (52W)-102.48%

Year-to-Date Return-38.55%

5-Day Price Return18.85%

EPS Normalized (Annual)$-1.62

ROA (5Y Avg)-1063.54%

Net Profit Margin (Annual)-95754.34%

Month-to-Date Return12.37%

EBITD / Share (Annual)$-1.56

Operating Margin (Annual)-97360.19%

EPS Basic Excl Extra (TTM)$-1.25

P/TBV (Quarterly)0.32x

P/B Ratio (Annual)0.87x

Inventory Turnover (TTM)0.54x

Pretax Margin (TTM)-198245.48%

Book Value / Share (Annual)$1.31

Price vs S&P 500 (13W)-5.60%

Beta1.22x

Revenue / Share (TTM)$0.00

ROE (TTM)-102.54%

52-Week Low$0.10

vGradeD

gGradeF

mGradeC

vgmGradeD

Show chart for

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.14

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
VRAXVirax Biolabs Group Limited Ordinary Shares	D	F	C	$0.21
IDXXIdexx Laboratories Inc	D	B	C	$562.16
LNTHLantheus Holdings, Inc	C	B	B	$100.98
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	B	$22.99
CLDXCelldex Therapeutics, Inc	F	F	C	$28.62
NEOGNeogen Corp	C	C	B	$8.90
NTLAIntellia Therapeutics, Inc	D	C	B	$13.54
QDELQuidelOrtho Corporation Common Stock	C	C	D	$14.33
ACHVAchieve Life Sciences, Inc.	F	F	B	$5.13
MYGNMyriad Genetics Inc	C	C	C	$4.57
TKNOAlpha Teknova, Inc. Common Stock	C	C	B	$4.56

About

Virax Biolabs is a biotechnology company specializing in immune response detection and viral disease diagnostics. The company offers research-use-only assays and immunology services through its ViraxImmune platform and ImmuneSelect portfolio. It is developing T cell-based diagnostic tests targeting post-acute infection syndromes, including Long COVID and other immune dysregulation-related conditions.